Browse > Article
http://dx.doi.org/10.5012/bkcs.2012.33.7.2219

Cytotoxic Activities of Amentoflavone against Human Breast and Cervical Cancers are Mediated by Increasing of PTEN Expression Levels due to Peroxisome Proliferator-Activated Receptor γ Activation  

Lee, Eun-Jung (Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University)
Shin, So-Young (Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University)
Lee, Jee-Young (Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University)
Lee, So-Jung (Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University)
Kim, Jin-Kyoung (Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University)
Yoon, Do-Young (Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University)
Woo, Eun-Rhan (College of Pharmacy, Chosun University)
Kim, Yang-Mee (Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University)
Publication Information
Abstract
Human peroxisome proliferator-activated receptor gamma ($hPPAR{\gamma}$) has been implicated in numerous pathologies, including obesity, diabetes, and cancer. Previously, we verified that amentoflavone is an activator of $hPPAR{\gamma}$ and probed the molecular basis of its action. In this study, we investigated the mechanism of action of amentoflavone in cancer cells and demonstrated that amentoflavone showed strong cytotoxicity against MCF-7 and HeLa cancer cell lines. We showed that $hPPAR{\gamma}$ expression in MCF-7 and HeLa cells is specifically stimulated by amentoflavone, and suggested that amentoflavone-induced cytotoxic activities are mediated by activation of $hPPAR{\gamma}$ in these two cancer cell lines. Moreover, amentoflavone increased PTEN levels in these two cancer cell lines, indicating that the cytotoxic activities of amentoflavone are mediated by increasing of PTEN expression levels due to $hPPAR{\gamma}$ activation.
Keywords
$PPAR{\gamma}$; Flavonoid; Amentoflavone; PTEN; Cancer;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 0  (Related Records In Web of Science)
연도 인용수 순위
1 Lehrke, M.; Lazar, M. A. Cell 2005, 123, 993-999.   DOI   ScienceOn
2 Tontonoz, P.; Spiegelman, B. M. Annu. Rev. Biochem. 2008, 77, 289-312.   DOI   ScienceOn
3 Krishnan, A.; Nair, S. A.; Pillai, M. R. Curr. Mol. Med. 2007, 7,532-540.   DOI
4 Steck, P. A.; Pershouse, M. A.; Jasser, S. A.; Yung, W. K.; Lin, H.; Ligon, A. H.; Langford, L. A.; Baumgard, M. L.; Hattier, T.; Davis, T.; Frye, C.; Hu, R.; Swedlund, B.; Teng, D. H.; Tavtigian, S. V. Nat. Genet. 1997, 15, 356-362.   DOI   ScienceOn
5 Herpin, A.; Lelong, C.; Favrel, P. Dev. Comp. Immunol. 2004, 28, 461-485.   DOI
6 Ye, J. Biochem. Biophys. Res. Commun. 2008, 374, 405-408.   DOI
7 Cazarolli, L. H.; Zanatta, L.; Alberton, E. H.; Figueiredo, M. S.; Folador, P.; Damazio, R. G.; Pizzolatti, M. G.; Silva, F. R. Mini Rev. Med. Chem. 2008, 8, 1429-1440.   DOI
8 Rajnaryana, K.; Sripalreddy, M.; Chalavadi, M. R.; Krishna, D. R. Indian J. Pharmacol. 2001, 33, 2-16.
9 Crozier, A.; Jaganath, I. B.; Clifford, M. N. Nat. Prod. Rep. 2009, 26, 1001-1043.   DOI
10 Butt, M. S.; Sultan, M. T. Crit. Rev. Food Sci. Nutr. 2009, 49, 463- 473.   DOI
11 Manas, E. S.; Xu, Z. B.; Unwalla, R. J.; Somers, W. S. Structure 2004, 12, 2197-2207.   DOI
12 Lee, J. Y.; Kim, J. K.; Cho, M. C.; Shin, S.; Yoon, D. Y.; Heo, Y. S.; Kim, Y. J. Nat. Prod. 2010, 73, 1261-1265.   DOI
13 Lee, J. Y.; Jung, K. W.; Woo, E. R.; Kim, Y. Bull. Korean Chem. Soc. 2008, 29, 1479-1484.   DOI
14 Lee, J. Y.; Kim, J.-K.; Lee, S.; Lee, E.; Shin, S.; Jin, Q.; Yoon, D.- Y.; Woo, E. R.; Kim, Y. Bull. Korean Chem. Soc. 2012, in press.
15 Selvam, C.; Jachak, S. M. J. Ethnopharmacol. 2004, 95, 209-212.   DOI
16 Silva, G. L.; Chai, H.; Gupta, M. P.; Farnsworth, N. R.; Cordell, G. A.; Pezzuto, J. M.; Beecher, C. W.; Kinghorn, A. D. Phytochemistry 1995, 40, 129-134.   DOI   ScienceOn
17 Lee, H. S.; Cho, M. C.; Paek, T. W.; Choe, Y. K.; Kim, J. W.; Hong, J. T.; Myung, P. K.; Paik, S. G.; Yoon, D. Y. J. Immunol. Methods 2005, 296, 125-134.   DOI
18 Banerjee, T.; Valacchi, G.; Ziboh, V. A.; van der Vliet, A. Mol. Cell. Biochem. 2002, 238, 105-110.   DOI
19 Hansen, M. K.; Connolly, T. M. Curr. Opin. Investig. Drugs 2008, 9, 247-255.
20 McKenna, N. J.; O'Malley, B. W. Endocrinology 2002, 143, 2461- 2465.   DOI
21 Berger, J. P.; Akiyama, T. E.; Meinke, P. T. Trends Pharmacol. Sci. 2005, 26, 244-251.   DOI   ScienceOn
22 Kersten, S.; Desvergne, B.; Wahli, W. Nature 2000, 405, 421-424.   DOI   ScienceOn
23 Berger, J.; Moller, D. E. Annu. Rev. Med. 2002, 53, 409-435.   DOI   ScienceOn
24 Chinetti-Gbaguidi, G.; Fruchart, J. C.; Staels, B. Curr. Opin. Pharmacol. 2005, 5, 177-183.   DOI
25 Chinetti, G.; Lestavel, S.; Bocher, V.; Remaley, A. T.; Neve, B.; Torra, I. P.; Teissier, E.; Minnich, A.; Jaye, M.; Duverger, N.; Brewer, H. B.; Fruchart, J. C.; Clavey, V.; Staels, B. Nat. Med. 2001, 7, 53-58.   DOI
26 Lee, C. H.; Olson, P.; Evans, R. M. Endocrinology 2003, 144, 2201-2207.   DOI   ScienceOn
27 Bocher, V.; Pineda-Torra, I.; Fruchart, J. C.; Staels, B. Ann. N. Y. Acad. Sci. 2002, 967, 7-18.
28 Markt, P.; Petersen, R. K.; Flindt, E. N.; Kristiansen, K.; Kirchmair, J.; Spitzer, G.; Distinto, S.; Schuster, D.; Wolber, G.; Laggner, C.; Langer, T. J. Med. Chem. 2008, 51, 6303-63017.   DOI
29 Rosen, E. D.; Spiegelman, B. M. J. Biol. Chem. 2001, 276, 37731- 37734.   DOI